Abstract: This article proposes a novel approach to suppress high-frequency oscillations and the resultant voltage overshoots in the transformer of dual active bridge converters that utilize ...

Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...

UCB, a global biopharmaceutical company, today announced that the final analysis of an open-label extension (OLE) study with ...